Retinal Vascular Disease Symposium

Related

• 

  Defining a 'Strong' and 'Weak' Response to Anti-VEGF Treatment CI-DME: Retrospective Analysis of 3 DRCR Retina Network Clinical Trials

  Sharon D. Solomon, MD

  Annual Meeting Talks

  2023

• 

  Novel Vascular Endothelial Growth-Factor A (VEGF-A) and Angiopoietin-2 (Ang-2) Bispecific Protein, RO-634, in Comparison to Aflibercept

  Mark R. Barakat, MD

  Annual Meeting Talks

  2022

• 

  Episode 14: Plasma VEGF Levels After Anti-VEGF Injections (DRCR protocol T) with Dr. Charles Wykoff

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

  2018